Below is a list of individual analysts that we are aware of that currently follow ContraVir Pharmaceuticals. 

Please note, that any opinions, estimates or forecasts regarding performance made by these analysts do not represent ContraVir Pharmaceuticals or its management team.  ContraVir Pharmaceuticalsis under no obligation to update this list, thus it may not be complete or up to date.

David Bautz, Ph.D.

Zacks Investment Research, Inc.
(312) 265-9471

Kumaraguru Raja, Ph.D.

Noble Life Science Partners
(212) 863-3225

Jason Kolbert

Maxim Group, LLC
(212) 895-3516

James Molloy

Laidlaw & Company
(857) 317-5061



print email